Navigation
Home
Advocating for Access
Background
Letters for Access
Press Releases For Access
Simplified Community Materials
Simplified Community Materials
Understanding your HCV infection
Community Led Reports
Country Information
Indonesia
India
Vietnam
Generic DAAs Pricing
Resources
Guidelines
Key Research Publication
Other Important Documents and Reports
News
Gallery
Photos
Video
Stories
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Pricing and availability of generic Indian Ledipasvir and Sofosbuvir co-formulation as on 26 April 2016
Download PDF
May 3, 2016
/
News
Share
the Post
Related
Posts
Read More
Story from Ayu Oktariani, Bandung, Indonesia
Availability and Pricing of Generic Sofosbuvir in India – Updated 10 September 2015
BMS’ patent bid for Hep C treatment Daclatasvir Challenged
IAC a community group in Indonesia demanding national food and drugs authority to expedite registration process of DAA medicines in Indonesia
Letter from Community in Asia and Eastern Europe to Global Fund Board for Financing Hep C Treatment
Patent Situation of The Key Product For Treatment of Hepatitis C: SOFOSBUVIR – WHO working paper, updated 2015
Hepatitis C Treatment Snapshots: Daclatasvir
Letter from Asian community and treatment advocates to Chief Executive Officer of CHAI regarding the Quick start program and concerns that patients would have to pay for sofosbuvir and diagnostics to be a part of the program in October 2016
